Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts

Molecular Reproduction and Development

Volumn 75, Issue 6, 2008, Pages 1071-1076

  Erickson, Robert P ^a,b   Cao, Wen ^a   Acuña, Diana K ^a   Strnatka, Diana W ^a   Hunter, Robert J ^a   Chau, Binh T ^c   Wakefield, Larissa V ^d   Sim, Edith ^d   Mcqueen, Charlene A ^c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b University of Arizona   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

6 aminonicotinamide; Cleft lip with or without cleft palate; Dilantin; Hydrocortisone; Isolated cleft palate

Indexed keywords

6 AMINONICOTINAMIDE; ARYLAMINE ACETYLTRANSFERASE; HYDROCORTISONE; PHENYTOIN; TERATOGENIC AGENT; ISOENZYME; MESSENGER RNA; N ACETYLTRANSFERASE 1; N-ACETYLTRANSFERASE 1; NAT2 ENZYME, MOUSE; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLEFT PALATE; CONTROLLED STUDY; ENZYME ASSAY; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENICS; A J MOUSE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CLEFT LIP; CONGENIC STRAIN; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PREGNANCY; SPECIES DIFFERENCE; TRANSGENIC MOUSE;

6-AMINONICOTINAMIDE; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; CLEFT LIP; CLEFT PALATE; DNA PRIMERS; FEMALE; HUMANS; HYDROCORTISONE; ISOENZYMES; MICE; MICE, CONGENIC; MICE, INBRED A; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PHENYTOIN; PREGNANCY; RNA, MESSENGER; SPECIES SPECIFICITY; TERATOGENS;

EID: 42949146499     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20852     Document Type: Article

References (32)

1. Atlas SA, Zweier JL, Nebert DW. 1980. Genetic differences in phenytoin pharmacokinetics in vivo clearance and in vitro metabolism among inbred strains of mice. Dev Pharmacol Ther 1:281-304.
2. Beck JT, Ullman B. 1989. Affinity labeling of the folate-methotrexate transporter from Leishmania donovani. Biochemistry 28:6931-6937.
3. Biddle FG, Fraser FC. 1976. Genetics of cortisone-induced cleft palate in the mouse-embryonic and maternal effects. Genetics 84:743-754.
4. Briggs RM. 1976. Vitamin supplementation as a possible factor in the incidence of cleft lip/palate deformities in humans. Clin Plast Surg 3:647-652.
5. Cao W, Chau B, Hunter R, Strnatka D. McQueen CA, Erickson RP. 2005. Only low levels of exogenous N-acetyltransferase can be achieved in transgenic mice. Pharmacogenomics J 5:255-261.
6. Cornish VA, Pinter K, Boukouvala S, Johnson N, Labrousse C, Payton M. 2003. Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene. Pharmacogenomics J 3:169-177.
7. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
8. De Leon JH, Martell KJ, Vatsis KP, Weber WW. 1995. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (Nat2 9). Drug Metab Disp 23:1354-1361.
9. Diehl SR, Erickson RP. 1997. Genome scan for teratogen-induced clefting susceptibility loci in the mouse: Evidence of both allelic and locus heterogeneity distinguishing cleft lip and cleft palate. Proc Natl Acad Sci USA 94:5231-5236.
10. Dunlevy LP, Burren KA, Chitty LS, Copp AJ, Greene ND. 2006. Excess methionine suppresses the methylation cycle and inhibits neural tube closure in mouse embryos. FEBS Lett 580:2803-2807.
11. Fraser FC, Fainstat TD. 1951. Production of congenital defects in the offspring of pregnant mice treated with cortisone. Pediatrics 8:527-533.
12. Friso S, Choi S-W, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J. 2002. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99:5606-5611.
13. Juriloff DM. 2002. Mapping studies in animal models. In: Wyszynski DF, editor. Cleft lip and palate. New York: Oxford University Press. p 265.
14. Juriloff DM, Harris MJ, Dewell SL. 2004. A digenic cause of cleft lip in A-strain mice and definition of candidate genes for the two loci. Birth Defects Res A Clin Mol Teratol 70:509-518.
15. Juriloff DM, Harris MJ, Dewell SL, Brown CJ, Mager DL, Gagnier L. 2005. Investigations of the genomic region that contains the clf1 mutation, a causal gene in multifactorial cleft lip and palate in mice. Birth Defects Res A Clin Mol Teratol 73:103-113.
16. Karolyi J, Erickson RP, Liu S, Killewald L. 1990. Major effects on teratogen-induced facial clefting in mice determined by a single genetic region. Genetics 126:201-205.
17. Karsai A, Miller S, Platz S, Hauser MT. 2002. Evaluation of a home-made SYBR Green I reaction mixture for real-time PCR quantification of gene expression. Biotechniques 32:790-796.
18. Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH. 2004. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol 70:846-852.
19. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. 1981. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 282:1509-1511.
20. Mattano SS, Weber SS. 1987. Kinetics of arylamine N-acetyltransferase in tissue from rapid and slow acetylator mice. Carcinogenesis 8:133-137.
21. Mattano SS, Erickson KP, Nesbitt MN, Weber WW. 1988. Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltransferase. J Hered 79:430-433.
22. McQueen CA, Mitchell KM, Dang LN, Chau B, Tjalkens RB, Philbert MA. 2003. Prenatal expression of N-acetyltransferase in C57Bl/6 mice. Chemico Biol Interact 145:77-87.
23. Minchin RF. 1995. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307:1-3.
24. Rosenquist TH, Finnell RH. 2001 Genes, folate and homocysteine in embryonic development. Proc Nutr Soc 60:53-61.
25. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. 1995. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 346:393-396.
26. Silver JM. 1995. Mouse genetics. New York: Oxford University Press. p 49.
27. Suh JR, Herbig AK, Stover PJ. 2001. New perspectives on folate catabolism. Annu Rev Nutr 21:255-282.
28. Tremolizzo L, Carboni G, Ruzicka WB, Mitchell CP, Sugaya I, Tueting P, Sharma R, Grayson DR, Costa E, Guidotti A. 2002. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci USA 99:17095-17100.
29. van Rooij IALM, Vermeij-Keers C, Kluijtmans LAJ, Ocké MC, Zielhuis GA, Goorhuis-Brouwer SM, van der Biezen JJ, Kuijpers-Jagtman AM, Steegers-Theunissen RP. 2003. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate? Am J Epidemiol 157:583-591.
30. Ward A, Summers MJ, Sim E. 1995. Purification of recombinant human N-aectyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 49:1759-1767.
31. Weber W. 1987. The acetylator genes and drug response. New York: Oxford University Press. pp 1-248.
32. vy/a mice. FASEB J 12:949-957.